Posted by mayzee on August 29, 2006, at 13:38:58
In reply to pharmacogenetics interview - nytimes, posted by crabwalk on August 29, 2006, at 12:54:31
I just came on to post the same article.
Glad she mentioned depression and other psychiatric diseases as areas that could benefit from pharmacogenetics.
Sad to read that the pharmas will be opposed to this approach since their business model can't accomodate it. TIME FOR A NEW BUSINESS MODEL, EH?
poster:mayzee
thread:681184
URL: http://www.dr-bob.org/babble/20060825/msgs/681197.html